These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8033500)

  • 1. Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men.
    Mustajoki P; Mustajoki S; Rautio A; Arvela P; Pelkonen O
    Clin Pharmacol Ther; 1994 Jul; 56(1):9-13. PubMed ID: 8033500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haem arginate improves hepatic oxidative metabolism in variegate porphyria.
    Tokola O; Mustajoki P; Himberg JJ
    Br J Clin Pharmacol; 1988 Dec; 26(6):753-7. PubMed ID: 3242580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid normalization of antipyrine oxidation by heme in variegate porphyria.
    Mustajoki P; Himberg JJ; Tokola O; Tenhunen R
    Clin Pharmacol Ther; 1992 Mar; 51(3):320-4. PubMed ID: 1544288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man.
    Sotaniemi EA; Lumme P; Arvela P; Rautio A
    Therapie; 1996; 51(4):363-6. PubMed ID: 8953808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease selectively modulates cytochrome P450--mediated metabolism.
    Frye RF; Zgheib NK; Matzke GR; Chaves-Gnecco D; Rabinovitz M; Shaikh OS; Branch RA
    Clin Pharmacol Ther; 2006 Sep; 80(3):235-45. PubMed ID: 16952490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria.
    Schuurmans MM; Hoffmann F; Lindberg RL; Meyer UA
    Hepatology; 2001 May; 33(5):1217-22. PubMed ID: 11343251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute attacks of hepatic porphyria: specific treatment with heme arginate].
    Nordmann Y; Deybach JC
    Ann Med Interne (Paris); 1993; 144(3):165-7. PubMed ID: 8368699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.
    Christensen M; Andersson K; Dalén P; Mirghani RA; Muirhead GJ; Nordmark A; Tybring G; Wahlberg A; Yaşar U; Bertilsson L
    Clin Pharmacol Ther; 2003 Jun; 73(6):517-28. PubMed ID: 12811361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats.
    Levere RD; Martasek P; Escalante B; Schwartzman ML; Abraham NG
    J Clin Invest; 1990 Jul; 86(1):213-9. PubMed ID: 2114425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of insulin-dependent diabetes on the metabolism of caffeine and the expression of the debrisoquin oxidation phenotype.
    Bechtel YC; Joanne C; Grandmottet M; Bechtel PR
    Clin Pharmacol Ther; 1988 Oct; 44(4):408-17. PubMed ID: 3168393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Carrier J; Khan IA; Edwards DJ; Shah A
    Clin Pharmacol Ther; 2004 Nov; 76(5):428-40. PubMed ID: 15536458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria.
    Dover SB; Moore MR; Fitzsimmons EJ; Graham A; McColl KE
    Gastroenterology; 1993 Aug; 105(2):500-6. PubMed ID: 8335204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
    Brandes LJ; Queen GM; LaBella FS
    Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of incorporating flurbiprofen into the Pittsburgh cocktail.
    Zgheib NK; Frye RF; Tracy TS; Romkes M; Branch RA
    Clin Pharmacol Ther; 2006 Sep; 80(3):257-63. PubMed ID: 16952492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.
    Frye RF; Matzke GR; Adedoyin A; Porter JA; Branch RA
    Clin Pharmacol Ther; 1997 Oct; 62(4):365-76. PubMed ID: 9357387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hepatic porphyrias: experience with 105 cases].
    Armas R; Wolff C; Krause P; Chaná P; Parraguez A; Soto J
    Rev Med Chil; 1992 Mar; 120(3):259-66. PubMed ID: 1342477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme arginate: effects on hemostasis.
    Volin L; Rasi V; Vahtera E; Tenhunen R
    Blood; 1988 Mar; 71(3):625-8. PubMed ID: 3345341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of CYP enzymes by quinidine and rifampin.
    Branch RA; Adedoyin A; Frye RF; Wilson JW; Romkes M
    Clin Pharmacol Ther; 2000 Oct; 68(4):401-11. PubMed ID: 11061580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.